May 05, 2023 / NTS GMT
Warren Ackerman - Barclays Investment Bank - Analyst
Hello, everybody. I'm Warren Ackerman, Head of Consumer Staples at Barclays. I'm delighted to be in Vevey, Nestlé's global headquarters with Mark Schneider, CEO of Nestlé. We've got a fireside chat. We've got an action-packed agenda. Thank you, Mark.
We're going to try to get through as many questions as possible, so let's get cracking.
Questions and Answers:
Warren Ackerman - Barclays Investment Bank - AnalystSo Mark, first question. Welcome. Can we just maybe start on M&A? Because since you've been CEO, you've rotated 20% of the portfolio and create a lot of value. However, there's been a few, maybe missteps recently, particularly Aimmune where you -- there's a write down happening.
What lessons have you learned from that? What are the potential outcomes from the Aimmune strategic review and how are you thinking about the bioscience's strategy within health sciences? And the reason why I asked this is because there is a little bit of concern about Ceres. Could it go the same way